Covid-19 is a leading cause of death in children and young people ages 0-19 years in the United States

Introduction

In the 12-month period April 1, 2021 - March 31, 2022, there were more than 381,000 deaths from Covid-19 in the US¹ (a rate of 115 / 100,000 population). In children and young people (CYP) aged 0-19 years there were 796 deaths from Covid-19 reported in this time period (1.0 / 100,000 population). The overall risk of death from Covid-19 in CYP is thus substantially less than in other age groups in the US. However, deaths in US CYP from all causes are rare (49.4 per 100,000 in 2019 for 0-19 year olds; 25.0 per 100,000 for 1-19 year olds); the mortality burden of Covid-19 is therefore best understood by comparing it to other significant causes of CYP mortality from a recent pre-Covid-19 period. For this purpose, we use the US Centers for Disease Control and Prevention (CDC) WONDER database of mortality statistics on underlying cause of death. Rankable causes of death are defined by the US National Center for Health Statistics (NCHS)’s grouping of the 113 Selected Causes of Death mortality tabulation list of ICD-10 codes for underlying cause of death. These were originally drawn up in 1951 to allow comparisons for public health purposes, and are regularly updated²: Covid-19 (ICD code U07.1) was added to this list in October 2020³. We consider the 10 leading causes of death in 2019, that is, the ordered list (1st through 10th) of causes that occur most frequently among NCHS’s rankable causes of death². Leading causes of death are one among various ways of understanding mortality and burden of disease. They are a starting point for a high-level understanding of public health priorities and resource allocation.

Methods

We obtained the 10 leading causes of death among the rankable groupings of underlying causes of death from the NCHS 113 Selected Causes of Death by age group in 2019 from CDC WONDER⁴, comprehensively described elsewhere². We compared these to Covid-19 mortality as an underlying cause of death in our study period, April 1, 2021-March 31, 2022, obtained from CDC WONDER Provisional Mortality Statistics¹ (the most recent 12-month period in which data is close to complete⁵.) An underlying cause of death is defined as a disease or injury that initiates a series of events leading directly to death. To determine pediatric death rates by cause of death, we used 2021 population size estimates by single year of age from the US Census Bureau⁶. We report crude death rates per 100,000 population.

We note that NCHS’s list of rankable causes of death usually group together many individual ICD codes², but Covid-19 is considered as a cause of death for a single ICD code, U07.1. Thus, we are comparing the underlying cause of death from a single pathogen (SARS-CoV-2) to groupings of multiple underlying causes of death (such as influenza and pneumonia). We also note that the CDC WONDER Provisional Mortality Statistics could still be revised in the future. In addition, they do not include deaths where Covid-19 was considered to have been a contributing cause of death,¹ and thus differ from other datasets reporting Covid-19 deaths, e.g. NCHS has a separate source reporting counts of deaths involving Covid-19⁷ (a previous version of this study incorrectly used these data⁸).

Results

Pediatric Covid-19 death rates follow a characteristic U-shaped curve across age groups in the US (Figure 1a), a commonly observed pattern^9,10. We consider five age brackets: <1 year, 1-4 years, 5-9 years, 10-14 years, and 15-19 years. In the study period, Covid-19 death rates in infants aged <1 year were 3.9 deaths per 100,000 population. The Covid-19 death rate was below 0.5 per 100,000 in children aged 1-4, 5-9, and 10-14 years old, increasing to 1.8 per 100,000 in 15-19-year olds.

• Download figure
• Open in new tab

Figure 1.

(a) Covid-19 death rates in the US for children and young people, where Covid-19 is listed as the underlying cause of death (ICD code U07.1) on the death certificate¹. Rates are calculated as Covid-19 deaths for the period April 1, 2021-March 31, 2022 per 100,000 population (2021 population estimates). (b) Monthly Covid-19 deaths in the US of children and young people, where Covid-19 is listed as the underlying cause of death (ICD code U07.1) on the death certificate¹.

• Download figure
• Open in new tab

Figure 2.

For children and young people aged 0-19 years in 2019, leading causes of death included heart disease (ranked 7th), influenza/pneumonia (8th), and cerebrovascular diseases (9th). We compare these causes of death to Covid-19 deaths in each 12 month period for which data is available: April 2020-March 2021, May 2020-April 2021, …, August 2021-July 2022.

In 2019, leading causes of CYP deaths aged 0-19 years (Table 1) were perinatal conditions (12.7 / 100,000), accidents (9.1 / 100,000), congenital malformations or deformations (6.5 / 100,000), assault (3.4 / 100,000), suicide (3.4 / 100,000), malignant neoplasms (2.1 / 100,000), diseases of the heart (1.1 / 100,000), and influenza and pneumonia (0.6 / 100,000).

For comparison, in the study period, April 1, 2021-March 31, 2022, there were 796 CYP deaths aged 0-19 years reported whose underlying cause was Covid-19 (1.0 / 100,000), meaning it ranks as the 8th leading cause of death (Table 1) and accounts for 2.3% of the 10 leading causes of death. Rankings disaggregated by age group are shown in Table 2, demonstrating that Covid-19 ranks consistently in the 10 leading causes of death in CYP in all age groups. Ranks are: 7th (<1 year olds), 7th (1-4 year olds), 6th (5-9 year olds), 6th (10-14 year olds), and 5th (15-19 year olds). Covid-19 accounted for 0.8% (<1 year old), 2.8% (1-4 year olds), 4.5% (5-9 year olds), 4.1% (10-14 year olds), and 4.2% (15-19 year olds) of the 10 leading causes of death by age group.

Excluding causes of death unrelated to disease (accidents, assault and suicide), Covid-19 ranked as the 5th leading cause of death in US CYP aged 0-19 years (Table 1). Considering infectious and respiratory diseases only, Covid-19 ranked as the top (1st) cause of death in US CYP aged 0-19 years (Table 3), followed by influenza and pneumonia as the 2nd leading cause (note that the causative agents of pneumonia may include multiple pathogens).

Note that for consistency, we have used the NCHS 113 Selected Causes of Death (which was designed for ages 1+) for all CYP age group disaggregations and combinations, rather than the NCHS 130 Selected Causes of Infant Death. Perinatal causes of death predominate for neonates and thus Covid-19 is not a leading cause of death in the first 28 days of life using the 130 Causes List (Supplementary Table 1). Restricting to the age group 28 days - 364 days using the 130 Causes List, Covid-19 is a top 10 leading cause of death (Supplementary Table 2).

Our study period, April 1, 2021-March 31, 2022, coincides with substantial Delta and Omicron waves (Figure 1b). As a sensitivity analysis, we considered every 12 month period from April 2020 to July 2022 (Figure 1b). In the pre-Delta period, before July 2021, Covid-19 death rates were considerably lower than in the Delta and Omicron periods. Nevertheless, Covid-19 in this period would have ranked as the 9th leading cause of death in 2019, rather than the 8th leading cause of death.

Conclusion

Early in the Covid-19 pandemic, comparisons of Covid-19 disease severity between age groups were a vital tool for appropriately allocating limited resources and prioritizing vaccination campaigns. However, long-term public health planning and management needs to be informed by the leading causes of deaths within each age group, a practice in the US dating back at least seven decades, beginning with the first publication of a leading cause of death ranking in 1952². The most recent comprehensive data pre-pandemic on leading causes of death covers 2019². Comparing to this period, we have shown that Covid-19 was a leading cause of death in CYP aged 0-19 years in the US for the period April 1, 2021-March 31, 2022, ranking 8th among all causes of deaths (comprising 2.4% of the 10 leading causes). Considering other 12 month periods during the pandemic does not qualitatively change our findings.

While other causes of death, such as accidents (22.5%), assault (8.4%) and suicide (8.3%) comprise a large percentage of the 10 leading causes of death, Covid-19 ranks 5th in disease-related causes of deaths (excluding accidents, assault and suicide), and 1st in deaths caused by infectious and respiratory diseases. Comparing deaths from Covid-19 with deaths from other vaccine-preventable diseases historically, Covid-19 caused substantially more deaths than major vaccine-preventable diseases did before vaccines became available: hepatitis A (3 deaths in children per year in the US), rotavirus (20-60 deaths), rubella (17 deaths), varicella (50 deaths)¹¹.

Our findings need to be considered in the context of several limitations which mean that we may underestimate the true mortality burden of Covid-19 in CYP aged 0-19 years. Analyses of excess deaths have suggested under-reporting bias in Covid-19 deaths¹²; specific criteria for determining Covid-19 deaths is heterogeneous across the US and has changed over time; and delays to reporting may be substantial, especially for recent time periods. We consider Covid-19 as an underlying (and not contributing) cause of death only, but Covid-19 amplifies the severe impacts of other diseases and mortality hazards from co-infection (e.g. influenza¹³) are increased with accompanying comorbidities. The category of deaths from “influenza and pneumonia” combines a variety of causes, to which SARS-CoV-2 could be a contributing factor^13,14. Recent evidence also suggests that Covid-19 may contribute to serious long-term sequelae¹⁵ in children and adolescents, which are unlikely to have been captured in these data.

In summary, we find that Covid-19 is now a leading cause of death for CYP aged 0-19 years in the US, and the top (1st) leading cause of death among infectious and respiratory diseases. Overall, deaths in CYP have increased over the Delta and Omicron waves compared to previous waves, likely reflecting the large numbers of CYP infected during these periods. A future variant or subvariant capable of displacing current Omicron subvariants will, by definition, have a growth advantage over Omicron, and there is no guarantee that its intrinsic severity will be reduced¹⁶. In the context of sustained transmission and circulation of SARS-CoV-2 in the US, the non-trivial risk posed by Covid-19 to CYP warrants utilization of a wide and robust array of tools to limit the extent of infection and severe disease in this age-group, through a combination of safe and efficacious vaccination against the disease¹⁷, appropriate pharmaceutical treatments, mitigations such as ventilation, and other non-pharmaceutical interventions.

Ethics

According to HRA decision tools (http://www.hra-decisiontools.org.uk/research/), our study is considered Research, and according to the NHS REC review tool (http://www.hra-decisiontools.org.uk/ethics/), we do not need NHS Research Ethics Committee (REC) review, as we only used (1) publicly available, (2) anonymized, and (3) aggregated data outside of clinical settings.

Funding

ES and SF acknowledge funding from the EPSRC (EP/V002910/2), OR from the MRC (MR/V038109/1). SM and SB acknowledge funding from the Novo Nordisk Young Investigator Award (NNF20OC0059309). CW acknowledges funding from the MRC DTP that supports his PhD studies (Award Ref 1975152). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript (AAM) version arising from this submission.

Code Availability

All data and R scripts for replicating the results in this manuscript are available from: https://github.com/flaxter/covid19pediatric/